CARMA: ready to analyze samples from 1st patient enrolled

Tags: | September 22nd, 2017

Samples from first CARMA patient enrolled at Imperial College Healthcare NHS Trust in London arrive in University College London Lab!


CARMA is a a multi-centre, cross-sectional study of children with perinatally acquired HIV-1 on sustained suppressive antiretroviral therapy started before 2 years of age. It is part of the EPIICAL study (Early treated Perinatally HIV Infected individuals: Improving Children’s Actual Life) , which is financed by ViiV Healthcare U.K. (ViiV).


We would like to update you on our recent activities